RT Conference Proceedings
T1 Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)
A1 Le Tourneau, C.
A1 Rischin, D.
A1 Groenland, S.
A1 Lim, A.
A1 Martin-Liberal, J.
A1 Moreno, V.
A1 Trigo, J. M.
A1 Mathew, M.
A1 Cho, D.
A1 Hansen, A.
A1 Baz, D. Vincente
A1 Maio, M.
A1 Italiano, A.
A1 Bauman, J.
A1 Chisamore, M.
A1 Zhou, H.
A1 Ellis, C.
A1 Ballas, M.
A1 Hoos, A.
A1 Angevin, E.
PB Oxford univ press
SN 0923-7534
YR 2020
FD 2020-03-01
LK https://hdl.handle.net/10668/27107
UL https://hdl.handle.net/10668/27107
LA en
DS RISalud
RD Apr 8, 2025